Latest filing published 22 Mar 2017 for Aurinia Pharmaceuticals Inc., €24.4M.
Filing timeline
BuySaleInsider track record
ILJIN SNT Co., Ltd.: trading record in brief
ILJIN SNT Co., Ltd. is a declared insider of Aurinia Pharmaceuticals Inc., with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 22 June 2016 to 20 March 2017.
The open-market record is one-sided, with 1 purchase worth €2.1M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2017 to date brings 1 purchase and no sales.
Most recently, on 22 March 2017, the filings show a transaction worth €24.4M in Aurinia Pharmaceuticals Inc. The most recent open-market purchase was published on 12 January 2017, 3,589 days ago. The median gap between a trade and its publication by SEC (Form 4) is 6 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to ILJIN SNT Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,185,185 shares@ CA$6.75100.0% of flowCommon SharesTSXSEDI:2982224
- 4,586,606 sharesCommon SharesTSXSEDI:2982223
- 1,333,333 shares@ CA$2.257.2% of flowCommon SharesTSXSEDI:2942049Canonical exit: 28 Mar 2017 (T+90)
- Common SharesTSXSEDI:2856840
- 1,694,915 shares@ CA$2.369.4% of flowCommon SharesTSXSEDI:2856841
5 of 5 declarations
